Form 4 holding
Director, 10%+ Owner
LEXICON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 1,538,462
- Estimated value
- $1,815,385
- Report date
- 02 Feb 2026
- Price
- $1.18
- Ownership
- Indirect
Avicenna Life Sci Master Fund LP
Insider Reports History
- Reporting-owner location
- New York, NY
- Latest reporting-owner signature
-
AVICENNA LIFE SCI MASTER FUND LP, By: Avicenna Life Sci Master GP LLC, its GP By: /s/ Raymond Debbane, Name: Raymond Debbane Title: Chief Executive Officer
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Avicenna Life Sci Master Fund LP
Insider Reports Filed by Avicenna Life Sci Master Fund LP
3
LXRX
LEXICON PHARMACEUTICALS, INC.
- Report period
- 02 Feb 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Feb 2026, 21:29
- Role
- Director, 10%+ Owner
- Next action
- Open filing details